跳至主要内容
临床试验/NCT06224023
NCT06224023招募中不适用

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Carol Davila University of Medicine and Pharmacy1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Mortality at 6 months

研究概览

简要总结

The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.

详细描述

Presepsin is a plasmatic cleaved fragment of CD14. CD14 is a toll like receptor who has the role to identify certain lipopolysaccharides on the surface of bacteria (aerobes and anaerobes), thus promoting an inflammatory response.

A study of 153 patients with liver cirrhosis published by a team of investigators from Iasi, Romania, has proven an useful role of plasma presepsin in early diagnosis of infections in patients in acute on chronic liver failure.

In addition, plasma presepsin has been proposed as an independent predictor of mortality in patients with decompensated liver cirrhosis, without concomitant bacterial infections.

Question to be answered by this study The investigators aim to evaluate the predictive role of ascites presepsin in patients with chronic liver failure.

Hypothesis Presepsin levels in ascites may have a prognostic role in patients with ascites and chronic liver failure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with ascites and chronic liver failure
  • no contraindications and technical possibility to perform diagnostic paracentesis
  • age above 18 years old
  • informed consent

排除标准

  • contraindications to paracentesis or technical impossibility to perform paracentesis
  • absence of informed consent

结局指标

主要结局

Mortality at 6 months

时间窗: 6 months

Number of who deceased during admission or during the 180 days after admission divided by the number of patients who were admitted. An analysis will be done to see if the presepsin levels are predictive for this event.

次要结局

  • Spontaneous bacterial peritonitis (SBP) rate(6 months)
  • Hepatic encephalopathy rate(6 months)
  • Any infection rate(6 months)

研究者

发起方
Carol Davila University of Medicine and Pharmacy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mihai Ciocirlan

Associate Professor of Gastroenterology

Carol Davila University of Medicine and Pharmacy

研究点 (1)

Loading locations...

相似试验